Ricardo Jiménez Camacho

Dr. Ricardo Jiménez Camacho

CINVESTAV, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in Viruses
Verified
Journal Article
Open access
PDF file
JOJuan Fidel Osuna-Ramos
Juan Fidel Osuna-Ramos
CMCarlos Noe Farfan Morales
Carlos Noe Farfan Morales
CRCarlos Daniel Cordero Rivera
Carlos Daniel Cordero Rivera
Luis Adrián De Jesús GonzálezLuis Adrián De Jesús González
Luis Adrián De Jesús González
José Manuel Reyes-RuizJosé Manuel Reyes-Ruiz
José Manuel Reyes-Ruiz
Rosa Del AngelRosa Del Angel
Rosa Del Angel
Flaviviruses, including Dengue (DENV), Zika (ZIKV), and Yellow Fever (YFV) viruses, represent a significant global health burden. The development of effective antiviral therapies against these viruses is crucial to mitigate their impact. This study investigated the antiviral potential of the cholesterol-lowering drugs atorvastatin and ezetimibe in monotherapy and combination against DENV, ZIKV, and YFV. In vitro results demonstrated a dose-dependent reduction in the percentage of infected cells for both drugs. The combination of atorvastatin and ezetimibe showed a synergistic effect against DENV 2, an additive effect against DENV 4 and ZIKV, and an antagonistic effect against YFV. In AG129 mice infected with DENV 2, monotherapy with atorvastatin or ezetimibe significantly reduced clinical signs and increased survival. However, the combination of both drugs did not significantly affect survival. This study provides valuable insights into the potential of atorvastatin and ezetimibe as antiviral agents against flaviviruses and highlights the need for further investigations into their combined therapeutic effects.

14 August 2024 in Marine Drugs
Verified
Journal Article
Open access
PDF file
BSBianca Vianey Rivera Serrano
Bianca Vianey Rivera Serrano
SCSandy Lucero Cabanillas-Salcido
Sandy Lucero Cabanillas-Salcido
CRCarlos Daniel Cordero Rivera
Carlos Daniel Cordero Rivera
RCRicardo Jiménez Camacho
Ricardo Jiménez Camacho
CNClaudia Desireé Norzagaray-Valenzuela
Claudia Desireé Norzagaray-Valenzuela
JOJuan Fidel Osuna-Ramos
Juan Fidel Osuna-Ramos
Dengue, caused by the dengue virus (DENV), is a global health threat transmitted by Aedes mosquitoes, resulting in 400 million cases annually. The disease ranges from mild to severe, with potential progression to hemorrhagic dengue. Current research is focused on natural antivirals due to challenges in vector control. This study evaluates the antiviral potential of peptides derived from the microalgae Phaeodactylum tricornutum, known for its bioactive compounds. Microalgae were cultivated under controlled conditions, followed by protein extraction and hydrolysis to produce four peptide fractions. These fractions were assessed for cytotoxicity via the MTT assay and antiviral activity against DENV serotype 2 using flow cytometry and plaque formation assays. The 10–30 kDa peptide fraction, at 150 and 300 μg/mL concentrations, demonstrated no cytotoxicity and significantly reduced the percentage of infected cells and viral titers. These findings suggest that peptides derived from Phaeodactylum tricornutum exhibit promising antiviral activity against dengue virus serotype 2, potentially contributing to developing new therapeutic approaches for dengue.

23 August 2025 in European Journal of Pharmacology
Verified
Journal Article
Open access
RCRicardo Jiménez Camacho
Ricardo Jiménez Camacho
Jose De Jesus Bravo SilvaJose De Jesus Bravo Silva
Jose De Jesus Bravo Silva
CCCarlos Daniel Cordero-Rivera
Carlos Daniel Cordero-Rivera
MBMagda Lizbeth Benítez-Vega
Magda Lizbeth Benítez-Vega
JCJonathan Hernández Castillo
Jonathan Hernández Castillo
Rosa Del AngelRosa Del Angel
Rosa Del Angel
Dengue is a viral disease caused by the dengue virus (DENV), which continues to pose a significant global public health challenge. This concern is particularly heightened by the rising incidence of dengue over the last two decades. While many infected individuals experience mild symptoms, a subset can progress to severe dengue, characterized by life-threatening hemorrhagic complications. Addressing this critical public health issue requires the development of new, safe, and effective treatments. In this study, the therapeutic potential of various metformin and phenformin analogs against DENV infection was evaluated. The antiviral effect was assessed by measuring the percentage of infected cells, as well as the levels of viral proteins and infectious viral particles. Additionally, DENV-infected AG129 mice were treated with two selected analogs and monitored for survival, weight changes, clinical signs, and viral RNA copies. The results demonstrated that these analogs effectively inhibited the number of infected cells, reduced viral protein levels, and decreased the formation of infectious viral particles. Furthermore, when compared to metformin (MET), certain analogs exhibited enhanced antiviral efficacy. Notably, we also found that the antiviral activity of the analogs correlated with increased levels of phosphorylated AMPK (pAMPK). In vivo treatments yielded significant antiviral effects, as evidenced by reduced clinical symptoms, lower mortality rates compared to untreated controls, and a marked reduction in viral load. These findings underscore the potential of biguanides derivatives as promising therapeutic agents against dengue infection, providing a foundation for further exploration of their antiviral properties.

27 January 2026 in Emerging Microbes & Infections
Verified
Journal Article
Open access
CRCarlos Daniel Cordero Rivera
Carlos Daniel Cordero Rivera
MVMagda Lizbeth Benítez Vega
Magda Lizbeth Benítez Vega
SPSelvin Palacios
Selvin Palacios
Jose De Jesus Bravo SilvaJose De Jesus Bravo Silva
Jose De Jesus Bravo Silva
RCRicardo Jiménez Camacho
Ricardo Jiménez Camacho
Rosa Del AngelRosa Del Angel
Rosa Del Angel
Dengue, transmitted by Aedes mosquitoes, can progress to severe symptoms like hemorrhagic fever and shock syndrome. While the virus and host immune response contribute to severity, other factors, such as small extracellular vesicles (sEVs), may play a role. sEVs mediate intercellular communication by transferring cellular components; however, their role in vivo infection remains unclear. We isolated and characterized sEVs from DENV-infected C6/36 mosquito cells, finding that they interact with mammalian cells and internalize the content. Using sEVs populations (with a size between 100 and 200 nm), we demonstrated enhanced infection in in vitro and in vivo murine models, including immunocompetent and immunosuppressed mice, which developed severe dengue-like symptoms. Our study reveals that sEVs from DENV-infected mosquito cells contribute to dengue pathogenesis, inducing severe symptoms in in vivo models, highlighting their potential role in disease progression and severe outcomes.

29 September 2025 in Viruses
Verified
Journal Article
Open access
PDF file
MVMagda Lizbeth Benítez Vega
Magda Lizbeth Benítez Vega
CRCarlos Daniel Cordero Rivera
Carlos Daniel Cordero Rivera
Jose De Jesus Bravo SilvaJose De Jesus Bravo Silva
Jose De Jesus Bravo Silva
RCRicardo Jiménez Camacho
Ricardo Jiménez Camacho
CMCarlos Noe Farfan Morales
Carlos Noe Farfan Morales
Rosa Del AngelRosa Del Angel
Rosa Del Angel
The cellular membrane is a dynamic structure composed of lipids and proteins organized into specialized domains that facilitate interactions between extracellular molecules and the intracellular environment. Tetraspanins are a family of transmembrane proteins involved in diverse cellular processes, including membrane stabilization and fusion, endocytosis, extracellular vesicle formation, and the organization of proteins and lipids at specific membrane sites known as Tetraspanin-Enriched Microdomains (TEMs). These lipid–protein interactions play a critical role in the replicative cycle of Orthoflavivirus, including dengue, Zika, and West Nile, by facilitating viral entry, replication, assembly, and egress. In addition, tetraspanins also regulate the biogenesis and function of extracellular vesicles, contributing to viral dissemination, persistent infection, and immune evasion. This review summarizes the current knowledge on the structural and functional aspects of tetraspanins, their interplay with lipids, and their emerging roles in the Orthoflavivirus replicative cycle. We also discuss how these insights may inform the development of antiviral strategies targeting membrane organization and virus–host interactions.